Publications

  1. Ehman EC, Johnson GB, Villanueva-Meyer JE, Cha S, Leynes AP, Larson PEZ, Hope TA. PET/MRI: Where might it replace PET/CT? J Magn Reson Imaging. 2017 Nov; 46 (5):1247-1262 Epub 2017 Mar 30
    View PubMed
  2. Mahmood M, Kendi AT, Farid S, Ajmal S, Johnson GB, Baddour LM, Chareonthaitawee P, Friedman PA, Sohail MR. Role of 18F-FDG PET/CT in the diagnosis of cardiovascular implantable electronic device infections: A meta-analysis. J Nucl Cardiol. 2017 Sep 14 Epub 2017 Sept 14
    View PubMed
  3. Nehra A, Parker WP, Haloi R, Park SS, Mynderse LA, Lowe VJ, Davis BJ, Quevedo JF, Johnson GB, Kwon ED, Karnes RJ. Identification of Recurrence Sites Following Post-Prostatectomy Treatment for Prostate Cancer Using 11C-Choline Positron Emission Tomography and Multiparametric Pelvic MRI. J Urol. 2017 Sep 12 Epub 2017 Sept 12
    View PubMed
  4. Chang I, Bois J, Bois M, Maleszewski J, Johnson G, Grogan M. Hydroxychloroquine-mediated cardiotoxicity with a false positive 99m-Technetium labeled pyrophosphate scan for transthyretin-related cardiac amyloidosis JACC.2017;
  5. Broski SM, Johnson GB, Goenka AH. Gastrointestinal: Multiparametric hybrid 18-FDG PETMRI evaluation of gastric adenocarcinoma. J Gastroenterol Hepatol. 2017 Jun; 32: (6)1132.
    View PubMed
  6. Venkatesh SK, Hennedige T, Johnson GB, Hough DM, Fletcher JG. Imaging patterns and focal lesions in fatty liver: a pictorial review. Abdom Radiol (NY). 2017 May; 42: (5)1374-1392.
    View PubMed
  7. Ravenel JG, Chung JH, Ackman JB, de Groot PM, Johnson GB, Jokerst C, Maldonado F, McComb BL, Steiner RM, Mohammed TL, Expert Panel on Thoracic Imaging:. ACR Appropriateness Criteria(R) Imaging of Possible Tuberculosis. J Am Coll Radiol. 2017 May; 14: (5S)S160-S165.
    View PubMed
  8. Sirajuddin A, Donnelly EF, Crabtree TP, Henry TS, Iannettoni MD, Johnson GB, Kazerooni EA, Maldonado F, Olsen KM, Wu CC, Mohammed TL, Kanne JP, Expert Panel on Thoracic Imaging:. ACR Appropriateness Criteria(R) Suspected Pulmonary Hypertension. J Am Coll Radiol. 2017 May; 14: (5S)S350-S361.
    View PubMed
  9. Leung N, Ramirez-Alvarado M, Nasr SH, Kemp BJ, Johnson GB. Detection of ALECT2 amyloidosis by positron emission tomography-computed tomography imaging with florbetapir. Br J Haematol. 2017 Apr; 177: (1)12.
    View PubMed
  10. Yanagisawa R, Fetterly KA, Johnson GB, Foley TA, Williamson EE, Gulati R, Sandhu GS, Frantz RP. Integrated Use of Perfusion SPECTCTA Fusion Imaging and Pulmonary Balloon Angioplasty for Chronic Pulmonary Thromboembolism. JACC Cardiovasc Interv. 2017 Mar 13; 10: (5)532-534.
    View PubMed
  11. Johnson GB, Aubry MC, Yi ES, Koo CW, Jenkins SM, Garces YI, Marks RS, Cassivi SD, Roden AC. Radiologic Response to Neoadjuvant Treatment Predicts Histologic Response in Thymic Epithelial Tumors. J Thorac Oncol. 2017 Feb; 12: (2)354-367.
    View PubMed
  12. Castano A, Haq M, Narotsky DL, Goldsmith J, Weinberg RL, Morgenstern R, Pozniakoff T, Ruberg FL, Miller EJ, Berk JL, Dispenzieri A, Grogan M, Johnson G, Bokhari S, Maurer MS. Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis. JAMA Cardiol. 2016 Nov 01; 1: (8)880-889.
    View PubMed
  13. Haddad MM, Merrell KW, Hallemeier CL, Johnson GB, Mounajjed T, Olivier KR, Fidler JL, Venkatesh SK. Stereotactic body radiation therapy of liver tumors: post-treatment appearances and evaluation of treatment response: a pictorial review. Abdom Radiol (NY). 2016 Oct; 41: (10)2061-77.
    View PubMed
  14. Martin-Macintosh EL, Broski SM, Johnson GB, Hunt CH, Cullen EL, Peller PJ. Multimodality Imaging of Neurodegenerative Processes: Part 2, Atypical Dementias. AJR Am J Roentgenol. 2016 Aug 9; 1-13.
    View PubMed
  15. Martin-Macintosh EL, Broski SM, Johnson GB, Hunt CH, Cullen EL, Peller PJ. Multimodality Imaging of Neurodegenerative Processes: Part 1, The Basics and Common Dementias. AJR Am J Roentgenol. 2016 Aug 9; 1-12.
    View PubMed
  16. Broski SM, Johnson GB, Howe BM, Nathan MA, Wenger DE, Spinner RJ, Amrami KK. Evaluation of (18)F-FDG PET and MRI in differentiating benign and malignant peripheral nerve sheath tumors. Skeletal Radiol. 2016 Aug; 45 (8):1097-105 Epub 2016 Apr 26
    View PubMed
  17. Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A, Wechalekar AD, Berk JL, Quarta CC, Grogan M, Lachmann HJ, Bokhari S, Castano A, Dorbala S, Johnson GB, Glaudemans AW, Rezk T, Fontana M, Palladini G, Milani P, Guidalotti PL, Flatman K, Lane T, Vonberg FW, Whelan CJ, Moon JC, Ruberg FL, Miller EJ, Hutt DF, Hazenberg BP, Rapezzi C, Hawkins PN. Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis. Circulation. 2016 Jun 14; 133 (24):2404-12 Epub 2016 Apr 22
    View PubMed
  18. Lehman VT, Murphy RC, Schenck LA, Carter RE, Johnson GB, Kotsenas AL, Morris JM, Nathan MA, Wald JT, Maus TP. Comparison of facet joint activity on 99mTc-MDP SPECTCT with facet joint signal change on MRI with fat suppression. Diagn Interv Radiol. 2016 May-Jun; 22: (3)277-83.
    View PubMed
  19. White ML, Johnson GB, Howe BM, Peller PJ, Broski SM. Spectrum of Benign Articular and Periarticular Findings at FDG PETCT. Radiographics. 2016 May-Jun; 36: (3)824-39.
    View PubMed
  20. Broski SM, Spinner RJ, Howe BM, Dispenzieri A, Johnson GB. 18F-Florbetapir and 18F-FDG PET/CT in Systemic Immunoglobulin Light Chain Amyloidosis Involving the Peripheral Nerves. Clin Nucl Med. 2016 Feb; 41: (2)e115-7.
    View PubMed
  21. Nelson DR, Johnson GB, Cartin-Ceba R, Specks U. Characterization of F-18 Fluorodeoxyglucose PETCT in Granulomatosis with Polyangiitis. Sarcoidosis Vasc Diffuse Lung Dis. 2016 Jan 18; 32: (4)342-52.
    View PubMed
  22. Bacchus L, Shah RD, Chung JH, Crabtree TP, Heitkamp DE, Iannettoni MD, Johnson GB, Jokerst C, McComb BL, Saleh AG, Steiner RM, Mohammed TL, Ravenel JG, Expert Panel on Thoracic Imaging. ACR Appropriateness Criteria Review ACR Appropriateness Criteria(R) Occupational Lung Diseases. J Thorac Imaging. 2016 Jan; 31: (1)W1-3.
    View PubMed
  23. Welle CL, Cullen EL, Peller PJ, Lowe VJ, Murphy RC, Johnson GB, Binkovitz LA. (1)(1)C-Choline PETCT in Recurrent Prostate Cancer and Nonprostatic Neoplastic Processes. Radiographics. 2016 Jan-Feb; 36: (1)279-92.
    View PubMed
  24. DeGrado TR, Kemp BJ, Pandey MK, Jiang H, Gunderson TM, Linscheid LR, Woodwick AR, McConnell DM, Fletcher JG, Johnson GB, Petersen RC, Knopman DS, Lowe VJ. First PET Imaging Studies With 63Zn-Zinc Citrate in Healthy Human Participants and Patients With Alzheimer Disease. Mol Imaging. 2016; 15:
    View PubMed
  25. Wells ML, Venkatesh SK, Chandan VS, Fidler JL, Fletcher JG, Johnson GB, Hough DM, Roberts LR. Biphenotypic hepatic tumors: imaging findings and review of literature. Abdom Imaging. 2015 Oct; 40: (7)2293-305.
    View PubMed
  26. Del Valle Somiedo Gutierrez M, Villasboas Bisneto JC, Lee CU, Johnson GB, Shen RK, Maldonado F. Pseudomyxoma pleuri. A rare manifestation of an uncommon disease. Am J Respir Crit Care Med. 2015 Jun 1; 191(11):1334-5.
    View PubMed
  27. Heitkamp DE, Albin MM, Chung JH, Crabtree TP, Iannettoni MD, Johnson GB, Jokerst C, McComb BL, Saleh AG, Shah RD, Steiner RM, Mohammed TL, Ravenel JG, Expert Panel on Thoracic Imaging. ACR Appropriateness Criteria(R) acute respiratory illness in immunocompromised patients. J Thorac Imaging. 2015 May; 30: (3)W2-5.
    View PubMed
  28. Brinjikji W, Boland Froemming JM, Holland WP, Peikert T, Johnson GB. Unexpectedly fludeoxyglucose (18F) avid well-differentiated adenocarcinoma of the lung. J Thorac Oncol. 2015 Apr; 10: (4)719-20.
    View PubMed
  29. Bartholmai BJ, Koo CW, Johnson GB, White DB, Raghunath SM, Rajagopalan S, Moynagh MR, Lindell RM, Hartman TE. Pulmonary nodule characterization, including computer analysis and quantitative features. J Thorac Imaging. 2015 Mar; 30: (2)139-56.
    View PubMed
  30. Dvorak LA, Vassallo R, Kirmani S, Johnson G, Hartman TE, Tazelaar HD, Leslie KO, Colby TV, Cockcroft DW, Churg AM, Yi ES. Pulmonary fibrosis in dyskeratosis congenita: report of 2 cases. Hum Pathol. 2015 Jan; 46: (1)147-52.
    View PubMed
  31. Johnson GB, Peller PJ, Kemp BJ, Ryu JH. Future of thoracic PET scanning. Chest. 2015 Jan; 147: (1)25-30.
    View PubMed
  32. Leung N, Grogan M, Johnson GB, Klecka ME, Dispenzeiri A. Pulmonary masses in a patient with dyspnea: Apply Occam's razor or Hickam's dictum? Am J Hematol. 2015; 90(5):462-5.
    View PubMed
  33. Platt JL, Wrenshall LE, Johnson GB, Cascalho M. Heparan sulfate proteoglycan metabolism and the fate of grafted tissues. Adv Exp Med Biol. 2015; 865:123-40.
    View PubMed
  34. Crush AB, Howe BM, Spinner RJ, Amrami KK, Hunt CH, Johnson GB, Murphy RC, Morreale RF, Peller PJ. Malignant involvement of the peripheral nervous system in patients with cancer: multimodality imaging and pathologic correlation. Radiographics. 2014 Nov-Dec; 34(7):1987-2007.
    View PubMed
  35. Broski SM, Hunt CH, Johnson GB, Morreale RF, Lowe VJ, Peller PJ. Structural and functional imaging in parkinsonian syndromes. Radiographics. 2014 Sep-Oct; 34: (5)1273-92.
    View PubMed
  36. Sun G, Tian J, Gorospe EC, Johnson GB, Hunt CH, Lutzke LS, Leggett CL, Iyer PG, Wang KK. Utility of baseline positron emission tomography with computed tomography for predicting endoscopic resectability and survival outcomes in patients with early esophageal adenocarcinoma. J Gastroenterol Hepatol. 2013 Jun; 28(6):975-81.
    View PubMed
  37. Clapp AJ, Hunt CH, Johnson GB, Peller PJ. Semiquantitative analysis of brain metabolism in patients with paraneoplastic neurologic syndromes. Clin Nucl Med. 2013 Apr; 38: (4)241-7.
    View PubMed
  38. Howe BM, Johnson GB, Wenger DE. Current concepts in MRI of focal and diffuse malignancy of bone marrow. Semin Musculoskelet Radiol. 2013 Apr; 17(2):137-44. Epub 2013 May 14.
    View PubMed
  39. McMenomy BP, Kurup AN, Johnson GB, Carter RE, McWilliams RR, Markovic SN, Atwell TD, Schmit GD, Morris JM, Woodrum DA, Weisbrod AJ, Rose PS, Callstrom MR. Percutaneous cryoablation of musculoskeletal oligometastatic disease for complete remission. J Vasc Interv Radiol. 2013 Feb; 24: (2)207-13.
    View PubMed
  40. Iqbal S, DePew ZS, Kurtin PJ, Sykes AM, Johnson GB, Edell ES, Habermann TM, Maldonado F. Endobronchial ultrasound and lymphoproliferative disorders: a retrospective study. Ann Thorac Surg. 2012 Dec; 94: (6)1830-4.
    View PubMed
  41. Broski SM, Hunt CH, Johnson GB, Subramaniam RM, Peller PJ. The added value of 18F-FDG PET/CT for evaluation of patients with esthesioneuroblastoma. J Nucl Med. 2012 Aug; 53: (8)1200-6.
    View PubMed
  42. Gu CN, Hunt CH, Lehman VT, Johnson GB, Diehn FE, Schwartz KM, Eckel LJ. Benign fibrous dysplasia on [(11)C]choline PET: a potential mimicker of disease in patients with biochemical recurrence of prostate cancer. Ann Nucl Med. 2012 Aug; 26(7):599-602. Epub 2012 Jun 07.
    View PubMed
  43. Chandler KJ, Hunt CH, Morreale R, Johnson GB, Peller PJ. Effect of patient age, breast density, and topical anesthetic cream on perceived pain with sentinel lymph node scintigraphy. J Nucl Med Technol. 2012 Mar; 40: (1)44-7.
    View PubMed
  44. Johnson GB, Peller PJ, Bahrami A, Subramaniam RM. AJR teaching file: left neck mass evaluated by PET/CT. AJR Am J Roentgenol. 2011 Jun; 196: (6 Suppl)WS78-82.
    View PubMed
  45. Kujak JL, Liu PT, Johnson GB, Callstrom MR. Early experience with percutaneous cryoablation of extra-abdominal desmoid tumors. Skeletal Radiol. 2010 Feb; 39 (2):175-82 Epub 2009 Sept 21
    View PubMed
  46. Brunn GJ, Bungum MK, Johnson GB, Platt JL. Conditional signaling by Toll-like receptor 4. FASEB J. 2005 May; 19(7):872-4. Epub 2005 Feb 28.
    View PubMed
  47. Johnson GB, Brunn GJ, Samstein B, Platt JL. New insight into the pathogenesis of sepsis and the sepsis syndrome. Surgery. 2005 Apr; 137(4):393-5.
    View PubMed
  48. Johnson GB, Riggs BL, Platt JL. A genetic basis for the "Adonis" phenotype of low adiposity and strong bones. FASEB J. 2004 Aug; 18(11):1282-4. Epub 2004 Jun 18.
    View PubMed
  49. Samstein B, Johnson GB, Platt JL. Toll-like receptor-4 and allograft responses. Transplantation. 2004 Feb 15; 77(3):475-7.
    View PubMed
  50. Johnson GB, Brunn GJ, Platt JL. Cutting edge: an endogenous pathway to systemic inflammatory response syndrome (SIRS)-Like reactions through toll-like receptor 4. J Immunol. 2004 Jan 1; 172(1):20-4.
    View PubMed
  51. Johnson GB, Brunn GJ, Tang AH, Platt JL. Evolutionary clues to the functions of the Toll-like family as surveillance receptors. Trends Immunol. 2003 Jan; 24(1):19-24.
    View PubMed
  52. Johnson GB, Brunn GJ, Platt JL. Activation of mammalian Toll-like receptors by endogenous agonists. Crit Rev Immunol. 2003; 23(1-2):15-44.
    View PubMed
  53. Johnson GB, Brunn GJ, Kodaira Y, Platt JL. Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by toll-like receptor 4. J Immunol. 2002 May 15; 168(10):5233-9.
    View PubMed
  54. Platt JL, Johnson GB, Kodaira Y, Wrenshall LE. Tolerance and the microenvironment. Transplantation. 2001 Oct 27; 72(8 Suppl):S23-4.
    View PubMed